Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Beata Chełstowska, Anna Barańczyk-Kuźma & Magdalena Kuźma-Kozakiewicz. (2021) Dyslipidemia in patients with amyotrophic lateral sclerosis – a case control retrospective study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 195-205.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
Cristina Moglia, Andrea Calvo, Antonio Canosa, Davide Bertuzzo, Paolo Cugnasco, Luca Solero, Maurizio Grassano, Enrica Bersano, Stefania Cammarosano, Umberto Manera, Fabrizio Pisano, Letizia Mazzini, Laura A. Dalla Vecchia, Gabriele Mora & Adriano Chiò. (2017) Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:7-8, pages 590-597.
Read now
Read now
Articles from other publishers (38)
Jee Eun Oh, Jee Ah Oh, Mary Demopoulos, Karen M Clark & Matthew CL Phillips. (2023) Impact of the metabolic syndrome on prevalence and survival in motor neuron disease: a retrospective case series. Metabolic Brain Disease 38:8, pages 2583-2589.
Crossref
Crossref
Satoru Morimoto, Shinichi Takahashi, Daisuke Ito, Yugaku Daté, Kensuke Okada, Chris Kato, Shiho Nakamura, Fumiko Ozawa, Chai Muh Chyi, Ayumi Nishiyama, Naoki Suzuki, Koki Fujimori, Tosho Kondo, Masaki Takao, Miwa Hirai, Yasuaki Kabe, Makoto Suematsu, Masahiro Jinzaki, Masashi Aoki, Yuto Fujiki, Yasunori Sato, Norihiro Suzuki, Jin Nakahara & Hideyuki Okano. (2023) Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell 30:6, pages 766-780.e9.
Crossref
Crossref
Wenjing Wang, Linjing Zhang, Kailin Xia, Tao Huang & Dongsheng Fan. (2023) Mendelian Randomization Analysis Reveals Statins Potentially Increase Amyotrophic Lateral Sclerosis Risk Independent of Peripheral Cholesterol-Lowering Effects. Biomedicines 11:5, pages 1359.
Crossref
Crossref
Mark R. Janse van Mantgem, Wouter van Rheenen, Anemone V. HackengMichael A. van EsJan H. Veldink, Leonard H. van den BergRuben P.A. van Eijk. (2023) Association Between Serum Lipids and Survival in Patients With Amyotrophic Lateral Sclerosis. Neurology 100:10.
Crossref
Crossref
Alisa V. Alessenko, Uliana A. Gutner & Maria A. Shupik. (2023) Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis. Life 13:2, pages 510.
Crossref
Crossref
Rajna Minić, Aleksandra Arsić, Milica Kojadinović, Aleksa Palibrk, Brizita Đorđević & Zorica Stević. (2023) Erythrocyte fatty acid aberrations in Amyotrophic Lateral Sclerosis: Correlation with disease duration. Journal of Medical Biochemistry 42:4, pages 621-629.
Crossref
Crossref
Audrey Labarre, Ericka Guitard, Gilles Tossing, Anik Forest, Eric Bareke, Marjorie Labrecque, Martine Tétreault, Matthieu Ruiz & J. Alex Parker. (2022) Fatty acids derived from the probiotic Lacticaseibacillus rhamnosus HA-114 suppress age-dependent neurodegeneration. Communications Biology 5:1.
Crossref
Crossref
Hannelore Hartmann, Wan Yun Ho, Jer‐Cherng Chang & Shuo‐Chien Ling. (2021) Cholesterol dyshomeostasis in amyotrophic lateral sclerosis: cause, consequence, or epiphenomenon?. The FEBS Journal 289:24, pages 7688-7709.
Crossref
Crossref
Tomomi Shijo, Naoki Suzuki, Hitoshi Warita, Yuko Kawauchi, Shio Mitsuzawa, Kensuke Ikeda, Rumiko Izumi, Risako Ono, Akiyuki Ohno, Masaya Toyoshima, Ryuhei Harada, Hiroshi Kuroda, Masaaki Kato & Masashi Aoki. (2022) Patients with lower limb‐onset ALS who have a longer duration from onset to diagnosis have a better prognosis. Neurology and Clinical Neuroscience 10:5, pages 239-244.
Crossref
Crossref
Nora Hertel, Magdalena Kuzma-Kozakiewicz, Marta Gromicho, Julian Grosskreutz, Mamede de Carvalho, Hilmi Uysal, Reinhard Dengler, Susanne Petri & Sonja Körner. (2022) Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study. Frontiers in Neurology 13.
Crossref
Crossref
Svitlana Garbuzova-Davis, Alison E. Willing & Cesario V. Borlongan. (2022)
Apolipoprotein A1 Enhances Endothelial Cell Survival in an
In Vitro
Model of ALS
. eneuro 9:4, pages ENEURO.0140-22.2022.
Crossref
Crossref
Andrew T. Nelson & Davide Trotti. (2022) Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis. Neurotherapeutics 19:4, pages 1102-1118.
Crossref
Crossref
Jin‐Yue Li, Li‐Ying Cui, Xiao‐Han Sun, Dong‐chao Shen, Xun‐Zhe Yang, Qing Liu & Ming‐Sheng Liu. (2022) Alterations in metabolic biomarkers and their potential role in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 9:7, pages 1027-1038.
Crossref
Crossref
Débora Lanznaster, Clément Bruno, Jérôme Bourgeais, Patrick Emond, Ilyess Zemmoura, Antoine Lefèvre, Pascal Reynier, Sébastien Eymieux, Emmanuelle Blanchard, Patrick Vourc'h, Christian R. Andres, Salah Eddine Bakkouche, Olivier Herault, Luc Favard, Philippe Corcia & Hélène Blasco. (2022) Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis. Biomedicines 10:6, pages 1307.
Crossref
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Crossref
Michael Sloth Trabjerg, Dennis Christian Andersen, Pam Huntjens, Kirsten Egelund Oklinski, Luise Bolther, Jonas Laugård Hald, Amalie Elton Baisgaard, Kasper Mørk, Nikolaj Warming, Ulla Bismark Kullab, Lona John Kroese, Colin Eliot Jason Pritchard, Ivo Johan Huijbers & John Dirk Vestergaard Nieland. (2021) Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Communications Biology 4:1.
Crossref
Crossref
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Lipid Profile in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Frontiers in Neurology 11.
Crossref
Crossref
Carlo F. Morasso, Daisy Sproviero, Maria Chiara Mimmi, Marta Giannini, Stella Gagliardi, Renzo Vanna, Luca Diamanti, Stefano Bernuzzi, Francesca Piccotti, Marta Truffi, Orietta Pansarasa, Fabio Corsi & Cristina Cereda. (2020) Raman spectroscopy reveals biochemical differences in plasma derived extracellular vesicles from sporadic Amyotrophic Lateral Sclerosis patients. Nanomedicine: Nanotechnology, Biology and Medicine 29, pages 102249.
Crossref
Crossref
Débora Lanznaster, Charlotte Veyrat-Durebex, Patrick Vourc’h, Christian R. Andres, Hélène Blasco & Philippe Corcia. (2020) Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis. Genes 11:5, pages 537.
Crossref
Crossref
Beata Chełstowska & Magdalena Kuźma-Kozakiewicz. (2020) Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurological Sciences 41:5, pages 1115-1124.
Crossref
Crossref
Caroline IngreLin ChenYiqiang ZhanJet TermorshuizenLi YinFang Fang. (2020) Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis. Neurology 94:17.
Crossref
Crossref
A.V. Alessenko, U.A. Gutner, V.O. Nebogatikov, M.A. Shupik & A.A. Ustyugov. (2020) The role of lipids in the pathogenesis of lateral amyotrophic sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:10, pages 108.
Crossref
Crossref
Claudia Marisol Sánchez-Martínez, José Alberto Choreño-Parra, Lilia Nuñez-Orozco, Noel Placencia-Álvarez, Laura Marcela Alvis-Castaño & Parménides Guadarrama-Ortiz. (2019) A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis. BMC Neurology 19:1.
Crossref
Crossref
Mariana Dutra Brito, Gustavo Ferro Gomes da Silva, Erick Mutti Tilieri, Beatriz Grisolia Araujo, Michele Longoni Calió & Tatiana Rosado Rosenstock. (2019) Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review. Frontiers in Neurology 10.
Crossref
Crossref
Olli Jääskeläinen, Eino Solje, Anette Hall, Kasper Katisko, Ville Korhonen, Mika Tiainen, Antti J. Kangas, Seppo Helisalmi, Maria Pikkarainen, Anne Koivisto, Päivi Hartikainen, Mikko Hiltunen, Mika Ala-Korpela, Hilkka Soininen, Pasi Soininen, Annakaisa Haapasalo, Anne M. Remes & Sanna-Kaisa Herukka. (2019) Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients. Journal of Alzheimer's Disease 72:1, pages 127-137.
Crossref
Crossref
Jose-Luis González De Aguilar. (2019) Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Siobhan E. Kirk, Timothy J. Tracey, Frederik J. Steyn & Shyuan T. Ngo. (2019) Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 10.
Crossref
Crossref
Ping Zeng & Xiang Zhou. (2019) Causal effects of blood lipids on amyotrophic lateral sclerosis: a Mendelian randomization study. Human Molecular Genetics 28:4, pages 688-697.
Crossref
Crossref
Ali Jawaid, Romesa Khan, Magdalini Polymenidou & Paul E. Schulz. (2018) Disease-modifying effects of metabolic perturbations in ALS/FTLD. Molecular Neurodegeneration 13:1.
Crossref
Crossref
Acsa Nara A. B. Barros, Mário Emílio T. Dourado, Lucia de Fatima C. Pedrosa & Lucia Leite-Lais. (2018) Association of Copper Status with Lipid Profile and Functional Status in Patients with Amyotrophic Lateral Sclerosis. Journal of Nutrition and Metabolism 2018, pages 1-7.
Crossref
Crossref
Hélène Blasco, Franck Patin, Amandine Descat, Guillaume Garçon, Philippe Corcia, Patrick Gelé, Timothée Lenglet, Peter Bede, Vincent Meininger, David Devos, Jean François Gossens & Pierre-François Pradat. (2018) A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLOS ONE 13:6, pages e0198116.
Crossref
Crossref
Rosa Burgos, Irene Bretón, Emanuele Cereda, Jean Claude Desport, Rainer Dziewas, Laurence Genton, Filomena Gomes, Pierre Jésus, Andreas Leischker, Maurizio Muscaritoli, Kalliopi-Anna Poulia, Jean Charles Preiser, Marjolein Van der Marck, Rainer Wirth, Pierre Singer & Stephan C. Bischoff. (2018) ESPEN guideline clinical nutrition in neurology. Clinical Nutrition 37:1, pages 354-396.
Crossref
Crossref
Hannah C. Timmins, Wilfred Saw, Benjamin C. Cheah, Cindy S.Y. Lin, Steve Vucic, Rebekah M. Ahmed, Matthew C. Kiernan & Susanna B. Park. (2017) Cardiometabolic health and risk of amyotrophic lateral sclerosis. Muscle & Nerve 56:4, pages 721-725.
Crossref
Crossref
H Blasco, F Patin, S Molinier, P Vourc'h, O Le Tilly, S Bakkouche, C R Andres, V Meininger, P Couratier & P Corcia. (2017) A decrease in blood cholesterol after gastrostomy could impact survival in ALS. European Journal of Clinical Nutrition 71:9, pages 1133-1135.
Crossref
Crossref
Archi Joardar, Ernesto Manzo & Daniela C. Zarnescu. (2017) Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities. Current Genetic Medicine Reports 5:2, pages 108-114.
Crossref
Crossref
Daniela Mariosa, John D. Beard, David M. Umbach, Rino Bellocco, Jean Keller, Tracy L. Peters, Kelli D. Allen, Weimin Ye, Dale P. Sandler, Silke Schmidt, Fang Fang & Freya Kamel. (2017) Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans. American Journal of Epidemiology 185:5, pages 362-371.
Crossref
Crossref
J. C. Wijnen. 2017. Informatorium voor Voeding en Diëtetiek. Informatorium voor Voeding en Diëtetiek
65
97
.
Franck Patin, Thomas Baranek, Patrick Vourc’h, Lydie Nadal-Desbarats, Jean-François Goossens, Sylviane Marouillat, Anne-Frédérique Dessein, Amandine Descat, Blandine Madji Hounoum, Clément Bruno, Hervé Watier, Mustafa Si-Tahar, Samuel Leman, Jean-Claude Lecron, Christian R. Andres, Philippe Corcia & Hélène Blasco. (2016) Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism. Neurotherapeutics 13:4, pages 905-917.
Crossref
Crossref